P66Shc restrains Ras hyperactivation and suppresses metastatic behavior

Oncogene

Volumn 29, Issue 41, 2010, Pages 5559-5567

  Ma, Z ^a,b   Liu, Z ^a,b   Wu, R F ^a   Terada, L S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

anoikis; metastasis; pRB; Shc; small cell lung cancer

Indexed keywords

PROTEIN P66; PROTEIN SHC; RAS PROTEIN; RETINOBLASTOMA PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANOIKIS; ARTICLE; CELL ADHESION; CELL PROLIFERATION; HUMAN; HUMAN CELL; LEWIS CARCINOMA; LUNG SMALL CELL CANCER; METASTASIS; METASTASIS INHIBITION; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANOIKIS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FOCAL ADHESIONS; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; RAS PROTEINS; RETINOBLASTOMA PROTEIN; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; SHC SIGNALING ADAPTOR PROTEINS; SMALL CELL LUNG CARCINOMA;

EID: 77957982069     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.326     Document Type: Article

References (26)

1. Attwell S, Roskelley C, Dedhar S. (2000). The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19: 3811-3815.
2. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS. (2004). Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430: 1034-1039.
3. Frisch SM, Francis H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626.
4. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. (1996). Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793-799.
5. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C et al. (2005). Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221-233.
6. Gonzalez SL, Stremlau M, He X, Basile JR, Munger K. (2001). Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J Virol 75: 7583-7591.
7. Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Lanfrancone L et al. (1998). High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res 58: 14-19.
8. Ho VM, Schaffer BE, Karnezis AN, Park KS, Sage J. (2009). The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras. Oncogene 28: 1393-1399.
9. Khanday FA, Santhanam L, Kasuno K, Yamamori T, Naqvi A, Dericco J et al. (2006). Sos-mediated activation of rac1 by p66shc. J Cell Biol 172: 817-822.
10. Lundberg AS, Hahn WC, Gupta P, Weinberg RA. (2000). Genes involved in senescence and immortalization. Curr Opin Cell Biol 12: 705-709.
11. Ma Z, Myers DP, Wu RF, Nwariaku FE, Terada LS. (2007). p66Shc mediates anoikis through RhoA. J Cell Biol 179: 23-31.
12. Mabry M, Nakagawa T, Nelkin BD, McDowell E, Gesell M, Eggleston JC et al. (1988). v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer. Proc Natl Acad Sci USA 85: 6523-6527.
13. McFall A, Ulku A, Lambert QT, Kusa A, Rogers-Graham K, Der CJ. (2001). Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase. Mol Cell Biol 21: 5488-5499.
14. Mettouchi A, Klein S, Guo W, Lopez-Lago M, Lemichez E, Westwick JK et al. (2001). Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol Cell 8: 115-127.
15. Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, Superti-Furga G et al. (1997). Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBOJ 16: 706-716.
16. Mittnacht S, Paterson H, Olson MF, Marshall CJ. (1997). Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein. Curr Biol 7: 219-221.
17. Okada S, Kao AW, Ceresa BP, Blaikie P, Margolis B, Pessin JE. (1997). The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J Biol Chem 272: 28042-28049.
18. Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R et al. (1997). Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386: 177-181.
19. Phelps WC, Yee CL, Munger K, Howley PM. (1988). The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53: 539-547.
20. Qiu RG, Chen J, Kirn D, McCormick F, Symons M. (1995). An essential role for Rac in Ras transformation. Nature 374: 457-459.
21. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ et al. (1998). Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 12: 95-106.
22. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
23. Takahashi C, Contreras B, Bronson RT, Loda M, Ewen ME. (2004). Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression. Mol Cell Biol 24: 10406-10415.
24. Takahashi C, Contreras B, Iwanaga T, Takegami Y, Bakker A, Bronson RT et al. (2006). Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor. Nat Genet 38: 118-123.
25. Wistuba II, Gazdar AF, Minna JD. (2001). Molecular genetics of small cell lung carcinoma. Semin Oncol 28: 3-13.
26. Wu RF, Ma Z, Myers DP, Terada LS. (2007). HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases. J Biol Chem 282: 37412-37419.